Translate page with Google

Story Publication logo November 2, 2020

What’s Happening With Remdesivir in Venezuela? (Spanish)

Country:

Author:
People wearing protective masks while waiting for turns to enter a supermarket during the COVID-19 pandemic in Caracas. Venezuela, 2020. Image by Edgloris Marys / Shutterstock.
English

Venezuelans are facing a complex humanitarian crisis. According to the United Nations, the Latin...

author #1 image author #2 image
Multiple Authors
SECTIONS
Vial of the drug remdesivir with syringe for COVID-19 treatment. Image by Bernard Chantal / Shutterstock. 2020.
Vial of the drug remdesivir with syringe for COVID-19 treatment. Image by Bernard Chantal / Shutterstock. 2020.

Doctors told Jesús that his wife needed a medication called remdesivir, but the clinic did not have it in stock and did not know where it could be found. Anobis was hospitalized due to COVID-19 at a small clinic in the state of Vargas, 55 kilometers from Caracas.

She had started remdesivir treatment at a clinic in Caracas, where she was hospitalized after being turned away from eight other clinics. No beds were available. Anobis was worried because she also had a condition called Bullous disease. Like COVID-19, it causes shortness of breath. On the third day of her hospital stay, they interrupted the treatment because they needed to remove her from the clinic. "The insurance denied the estimated $1,800 dollars that the clinic charged for hospitalization per day," said Anobis. That night, she and her husband spent the night at her house in Vargas, and the following morning they searched for a clinic that the insurance would cover. They found Hospital San José by the Sisters of the Poor.

Remdesivir, an antiviral drug that was proven to combat Ebola in 2014, received a lot of attention in April when a scientific trial suggested clinical benefits for a certain type of COVID-19 patient. 

At the end of July, the Venezuelan government included it in the medical protocol of medications used to treat COVID-19. According to these guidelines, remdesivir should be given to both those suspected of having COVID-19 and to those infected who have comorbidity and have mild respiratory issues. It should also be given to the confirmed [positive] and suspected patients who display moderate or severe insufficiency, as well as those who have the same symptoms and are intubated.

To continue reading in Spanish, click here.

RELATED TOPICS

navy halftone illustration of a covid virus

Topic

COVID-19

COVID-19
navy halftone illustration of a female doctor with her arms crossed

Topic

Health Inequities

Health Inequities
navy halftone illustration of a group of pharmaceutical pills

Topic

Outbreaks and Epidemics

Outbreaks and Epidemics

Support our work

Your support ensures great journalism and education on underreported and systemic global issues